Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 14,593-14,604 of 23,847

Behavioral study icon

CompletedNCT04615741

Finding Wellness in the Pandemic

This summary needs review. Please check the official study record and contact the research team for details.

In Lethbridge

AddictionBehavioralFrom 18 Years to 75 Years

Countries: Canada
Sponsor: University of Lethbridge
Condition: Addiction

Drug study icon

CompletedNCT01779700

Fingolimod in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Indianapolis

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indiana University
Condition: Schizophrenia

Behavioral study icon

CompletedNCT03386409

Firearm Storage Device Distribution to Families of Children With Mental Health Complaints

This summary needs review. Please check the official study record and contact the research team for details.

In Seattle

SuicidalityBehavioralUp to 17 Years

Countries: United States
Sponsor: Seattle Children's Hospital
Condition: Suicidality

Behavioral study icon

Active Not RecruitingNCT05242627

Firearm-Safety Counseling: Medical Student Training

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles

SuicidalityBehavioralOver 18 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Suicidality

Behavioral study icon

CompletedNCT04386330

Firefighters Accessing Care for Trauma: A Clinical Case Series of Distance NET for PTSD/I Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In Fredericton

PTSDBehavioralOver 19 Years

Countries: Canada
Sponsor: IWK Health Centre
Condition: PTSD

Other study type icon

CompletedNCT01753284

First Episode Psychosis and Pathway to Care in Nordland

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

SchizophreniaOtherFrom 16 Years to 35 Years

Countries
Sponsor: Nordlandssykehuset HF
Condition: Schizophrenia

Drug study icon

CompletedNCT00573287

First Episode Schizophrenia and Cannabis-Related Disorder Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Concord

Schizophrenia, AddictionDrugFrom 17 Years to 45 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Addiction

Behavioral study icon

CompletedNCT05998005

First Face Training Evaluation in Tribal Communities

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bonners Ferry

AddictionBehavioralOver 14 Years

Countries: United States
Sponsor: Cambridge Health Alliance
Condition: Addiction

Drug study icon

CompletedNCT02765555

First in Man Study of Safety, Tolerability and PK Profile of RBP-7000

This study is completed in the United States. It focuses on Schizophrenia.

In Willingboro

SchizophreniaDrugFrom 18 Years to 42 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Schizophrenia

Other study type icon

CompletedNCT06268899

First Mobilization Protocol for Total Knee Arthroplasty Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Ankara

AnxietyOtherOver 18 Years

Countries: Türkiye
Sponsor: Gazi University
Condition: Anxiety

Drug study icon

CompletedNCT01381419

First Time in Human Study (FTIH) With Positron Emission Tomography (PET)

This summary needs review. Please check the official study record and contact the research team for details.

In Harrow

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United Kingdom
Sponsor: GlaxoSmithKline
Condition: Schizophrenia

Drug study icon

CompletedNCT00527020

First Time in Human Study With GSK1018921

This summary needs review. Please check the official study record and contact the research team for details.

In Berlin

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: Germany
Sponsor: GlaxoSmithKline
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.